Supriya Lifescience Limited - Outcome of Board Meeting

10 Nov 2022 , 12:00 AM

Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company at its Meeting held on Thursday, November 10, 2022, inter-alia, has:1. Considered and approved the Unaudited Financial Results for the Quarter and six months ended September 30, 2022.2. Approved appointment of M/s. DSM & Associates, Practising Company Secretaries as Secretarial Auditor for the financial year 2022-23;3. Approved appointment of M/s. Nair???s & Panicker???s, Audit & Advisory Services, as Internal Auditor for the financial year 2022-23;